That means that it basically mimics two hormones (GIP and GLP-1)
Youll progress through the 0.5 mg, 1.0 mg, and 1.7 mg doses, with each increase typically bringing stronger appetite suppression
While this study was not a head-to-head clinical trial comparison, it may be relevant that at week 12 of a weekly dosing regimen, some studies suggest that participants treated with semaglutide (Wegovy, Novo Nordisk) had an approximately 6% decrease from baseline in body weight, whereas those treated with tirzepatide (Zepbound, Eli Lilly) had an approximately 8% decrease from baseline in body weight at the same time period, Bays said
Patients interested in learning about peptide therapy, medical weight loss, and individualized wellness planning can schedule a consultation with Sage Wellness and Medspa in Plantation, Florida